These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3228086)

  • 1. Drug-use evaluation of thrombolytic agents: a challenge to pharmacists.
    Green JA
    Am J Hosp Pharm; 1988 Oct; 45(10):2192-4. PubMed ID: 3228086
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing guidelines for thrombolytic therapy.
    Comer JB; Emanuelsen KL; Drezner AD; Knauft RF
    Am J Hosp Pharm; 1984 Nov; 41(11):2374-7. PubMed ID: 6548871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does your committee pass the McNemar test?
    Owen JA
    Hosp Formul; 1979 Jun; 14(6):605. PubMed ID: 10242200
    [No Abstract]   [Full Text] [Related]  

  • 6. The other side of the fence: hospital P&T committee members' role in drug selection.
    Archambault GF
    Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of the Pharmacy and Therapeutics Committee in materiel management.
    Moss RL; Bowman JD; Smith W
    Hosp Mater Manage Q; 1990 Feb; 11(3):61-5. PubMed ID: 10103649
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global formulary review: how do we integrate pharmacogenomic information?
    Poppe LB; Roederer MW
    Ann Pharmacother; 2011 Apr; 45(4):532-8. PubMed ID: 21487085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to develop a proactive formulary system.
    Crane VS; Gonzalez ER; Hull BL
    Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When the pharmacy and therapeutics committee decides.
    Garrison TJ
    Hosp Pharm; 1979 Sep; 14(9):506-7. PubMed ID: 10243912
    [No Abstract]   [Full Text] [Related]  

  • 14. The drug formulary decision-making process.
    Brehany J; Cohen P; Sax MJ
    Healthplan; 1999; 40(3):85-92. PubMed ID: 10538088
    [No Abstract]   [Full Text] [Related]  

  • 15. Rational formulary selection of antimicrobials.
    DiPiro JT; Steele JC
    Am J Hosp Pharm; 1987 Jan; 44(1):74. PubMed ID: 3826091
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoeconomic analysis in formulary decisions: an international perspective.
    Johnson JA; Bootman JL
    Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal issues associated with formulary product-selection when there are two or more recognized drug therapies.
    Liang FZ; Greenberg RB; Hogan GF
    Am J Hosp Pharm; 1988 Nov; 45(11):2372-5. PubMed ID: 3228094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSRO: will pharmacy and medicine now work together?
    Jeffrey LP
    Hosp Formul; 1975 Jun; 10(6):283-6. PubMed ID: 10273081
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug management. Making introductions.
    Russell E; Bool P
    Health Serv J; 1999 Feb; 109(5643):28-9. PubMed ID: 10387432
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.